UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.360

Sortiert nach

Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment

Biotechnology advances, 2011, Vol.29 (1), p.1-10

2011

Volltextzugriff (PDF)

Proposed Update of Angiotensin Receptor Nomenclature

Hypertension (Dallas, Tex. 1979), 1995-05, Vol.25 (5), p.924-927

1995

Volltextzugriff (PDF)

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

Journal of medicinal chemistry, 1991-08, Vol.34 (8), p.2525-2547

1991

Volltextzugriff (PDF)

Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment

Biotechnology advances, 2010-11, Vol.28 (6), p.715-724

2010

Volltextzugriff (PDF)

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives

Journal of medicinal chemistry, 1990-05, Vol.33 (5), p.1312-1329

1990

Volltextzugriff (PDF)

Identification of angiotensin II receptor subtypes

Biochemical and biophysical research communications, 1989-11, Vol.165 (1), p.196-203

1989

Volltextzugriff (PDF)

Nomenclature for Angiotensin Receptors A Report of the Nomenclature Committee of the Council for High Blood Pressure Research

Hypertension (Dallas, Tex. 1979), 1991-05, Vol.17 (5), p.720-721

1991

Volltextzugriff (PDF)

The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist

Medicinal research reviews, 1992-03, Vol.12 (2), p.149-191

1992

Volltextzugriff (PDF)

Hypotensive Action of DuP 753, an Angiotensin II Antagonist, in Spontaneously Hypertensive Rats Nonpeptide Angiotensin II Receptor Antagonists: X

Hypertension (Dallas, Tex. 1979), 1990-05, Vol.15 (5), p.459-468

1990

Volltextzugriff (PDF)

Angiotensin II Receptor Antagonists From Discovery to Antihypertensive Drugs

Hypertension (Dallas, Tex. 1979), 1991-11, Vol.18 (5 Suppl III), p.III-136-III-142

1991

Volltextzugriff (PDF)

DuP 532: A second generation of nonpeptide angiotensin II receptor antagonists

Biochemical and biophysical research communications, 1991-05, Vol.177 (1), p.209-217

1991

Volltextzugriff (PDF)

The preclinical basis of the therapeutic evaluation of losartan

Journal of hypertension, 1995-07, Vol.13 Suppl 1 (1), p.S1-S13

1995

Volltextzugriff (PDF)

Angiotensin II receptors and angiotensin II receptor antagonists

Pharmacological reviews, 1993-06, Vol.45 (2), p.205

1993

Volltextzugriff (PDF)

A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site

Journal of medicinal chemistry, 1993-12, Vol.36 (25), p.3985-3992

1993

Volltextzugriff (PDF)

Balanced AT1/AT2 Receptor Antagonists. 4. XR510 and Related 5-(3-Amidopropanoyl)imidazoles Possessing Equal Affinity for the AT1 and AT2 Receptors

Journal of medicinal chemistry, 1995-07, Vol.38 (15), p.2938-2945

1995

Volltextzugriff (PDF)

Angiotensin II exerts its effect on aldosterone production and potassium permeability through receptor subtype at1 in rat adrenal glomerulosa cells

Biochemical pharmacology, 1992-03, Vol.43 (5), p.1009-1012

1992

Volltextzugriff (PDF)

Properties of Angiotensin II Receptors of Domestic Turkey (Meleagris gallopavo) Adrenal Steroidogenic Cells

General and comparative endocrinology, 1994-10, Vol.96 (1), p.92-107

1994

Volltextzugriff (PDF)

Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position

Bioorganic & medicinal chemistry letters, 1994-09, Vol.4 (18), p.2235-2240

1994

Volltextzugriff (PDF)

The preparation of (perfluoroalkyl)imidazoles as nonpeptide angiotensin II receptor antagonists

Bioorganic & medicinal chemistry letters, 1993-05, Vol.3 (5), p.895-898

1993

Volltextzugriff (PDF)

Characterization of angiotensin AT1A receptor isoform by its ligand binding signature

Regulatory peptides, 1993-03, Vol.44 (2), p.141-147

1993

Volltextzugriff (PDF)

Synthesis and pharmacological properties of [5-isoleucine]-, [8-isoleucine]-, and [5,8-diisoleucine]bradykinin

Journal of medicinal chemistry, 1979-03, Vol.22 (3), p.334-335

1979

Volltextzugriff (PDF)

Nonpeptide angiotensin II receptor antagonists

Trends in Pharmacological Sciences, 1991-02, Vol.12 (2), p.55-62

1991

Volltextzugriff (PDF)

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent

The Journal of pharmacology and experimental therapeutics, 1990-10, Vol.255 (1), p.211

1990

Volltextzugriff (PDF)

Pharmacology of XR510, a Potent Orally Active Nonpeptide Angiotensin II AT1 Receptor Antagonist with High Affinity for the AT2 Receptor Subtype

Journal of cardiovascular pharmacology, 1995-09, Vol.26 (3), p.354-362

1995

Volltextzugriff (PDF)

Angiotensin II Receptors and Functional Correlates

American journal of hypertension, 1992-12, Vol.5 (12-Pt-2), p.221S-235S

1992

Volltextzugriff (PDF)

1 – 25 von 1.360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.222)
Mit Volltextzugriff
(1.234)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.355)
Japanisch
(161)
Chinesisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(867)
Life Sciences & Biomedicine
(674)
Humans
(513)
Male
(283)
Female
(282)
Animals
(185)
Middle Aged
(184)
Adult
(166)
Biological And Medical Sciences
(164)
Physical Sciences
(135)
Aged
(127)
Medical Sciences
(121)
Technology
(105)
Biochemistry & Molecular Biology
(94)
Chemistry
(87)
Surgery
(86)
Science & Technology - Other Topics
(84)
Molecular Sequence Data
(76)
Amino Acid Sequence
(70)
Mice
(66)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment

Proposed Update of Angiotensin Receptor Nomenclature

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives

Identification of angiotensin II receptor subtypes

Nomenclature for Angiotensin Receptors A Report of the Nomenclature Committee of the Council for High Blood Pressure Research

The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist

Hypotensive Action of DuP 753, an Angiotensin II Antagonist, in Spontaneously Hypertensive Rats Nonpeptide Angiotensin II Receptor Antagonists: X

Angiotensin II Receptor Antagonists From Discovery to Antihypertensive Drugs

DuP 532: A second generation of nonpeptide angiotensin II receptor antagonists

The preclinical basis of the therapeutic evaluation of losartan

Angiotensin II receptors and angiotensin II receptor antagonists

A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site

Balanced AT1/AT2 Receptor Antagonists. 4. XR510 and Related 5-(3-Amidopropanoyl)imidazoles Possessing Equal Affinity for the AT1 and AT2 Receptors

Angiotensin II exerts its effect on aldosterone production and potassium permeability through receptor subtype at1 in rat adrenal glomerulosa cells

Properties of Angiotensin II Receptors of Domestic Turkey (Meleagris gallopavo) Adrenal Steroidogenic Cells

Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position

The preparation of (perfluoroalkyl)imidazoles as nonpeptide angiotensin II receptor antagonists

Characterization of angiotensin AT1A receptor isoform by its ligand binding signature

Synthesis and pharmacological properties of [5-isoleucine]-, [8-isoleucine]-, and [5,8-diisoleucine]bradykinin

Nonpeptide angiotensin II receptor antagonists

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent

Pharmacology of XR510, a Potent Orally Active Nonpeptide Angiotensin II AT1 Receptor Antagonist with High Affinity for the AT2 Receptor Subtype

Angiotensin II Receptors and Functional Correlates

Suchergebnisse filtern